GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Drug Free Solution DSOL · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2017FY2025

Net income

−$6,692

FY2017FY2025

Free cash flow

—

FY2017FY2025

Shareholders' equity

—

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2020FY2019FY2018FY2017
Revenue———$805$1,766—$150,090
Operating income−$6,692−$12,501−$26,332−$1.4m−$1.4m−$233,330−$67,090
Net income−$6,692−$12,501−$26,332−$1.4m−$1.5m−$233,332−$67,092
Diluted earnings per share-0.00-0.00-0.00-0.00-0.01-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2020FY2019FY2018FY2017
Total assets———$52,507$18,048——
Cash and short-term investments———$12,502$2,526——
Total liabilities———$333,299$256,299——
Shareholders' equity———−$280,792−$238,252——
Shares outstanding283m444m283m283m283m283m283m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2020FY2019FY2018FY2017
Cash from operations———−$382,901−$401,503—−$22,259
Capital spending———−$36,831−$18,800——
Free cash flow———−$419,732−$420,303—−$22,259

Latest quarters

By quarter end

Aug 2024Feb 2021Feb 2014Nov 2013Aug 2013May 2013Feb 2013Nov 2012
Revenue———$2————
Operating income−$8,406−$1,940−$120−$125−$50−$572−$115−$36
Net income−$8,406−$1,943−$120−$125−$50−$572−$115−$36
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.01-0.00-0.00
Total assets——$52$50$5$11,795$33$9
Cash and short-term investments——$7$1$2$8,157$26$2
Debt————$39——$14
Shareholders' equity——−$339−$219−$101−$50,790$1−$30

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-83.2%-50.9%—
Net income-83.2%-50.9%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2020FY2019
Price to earnings-46.6-7.1-2.1-2.9-0.1
Price to sales————55.9

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return450%0%100%-98%-65%4552%31790%310%303%81%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3-for-1 split · 9 Jan 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.